Break
GBP/NZD - Short Position AnalysisThis pair has fallen around 220 pips since an initial entry was identified.
Price broke this ascending trendline, retraced to a key level in price on the LTF coinciding with trendline rejection with wicks forming to the upside.
Zoom out and you'll see GN is at the top of the range and through cross analysis you can identify that this currency pair is strength vs strength.
Any questions feel free to drop me a private message.
$CASI KST Buy Signal CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical products and various therapeutics in China, the United States, and internationally. The company's product pipeline includes EVOMELA, a melphalan hydrochloride for injection primarily for use as a high-dose conditioning treatment prior to hematopoietic progenitor cell transplantation in patients with multiple myeloma. Its product pipeline also comprise CNCT19, an autologous CD19 CAR-T investigative product for the treatment of patients with B-cell acute lymphoblastic leukemia (B-ALL) and B-cell non-Hodgkin lymphoma; CID-103, an anti-CD38 monoclonal antibody being for the treatment of patients with multiple myeloma; ZEVALIN, a CD20-directed radiotherapeutic antibody, to treat patients with NHL; and Thiotepa, a chemotherapeutic agent, which has multiple indications including use as a conditioning treatment for use prior to hematopoietic stem cell transplantation. In addition, the company offers MARQIBO, a microtubule inhibitor, approved by the FDA for the treatment of adult patients with Philadelphia chromosome-negative ALL; and Octreotide LAI formulations for the treatment of acromegaly and for the control of symptoms associated with various neuroendocrine tumours, as well as developing a portfolio of 25 FDA-approved abbreviated new drug applications. It has licensing agreements with Black Belt Therapeutics Limited; Juventas Cell Therapy Ltd.; Pharmathen Global BV; and Cleave Therapeutics, Inc. The company was formerly known as EntreMed, Inc. and changed its name to CASI Pharmaceuticals, Inc. in June 2014. CASI Pharmaceuticals, Inc. was founded in 1991 and is based in Rockville, Maryland.
Don't miss this amazing EURGBP break!Hey there, EURGBP is going to break the downtrend from upper line, it is following an small uptrend even in price and rsi and I'm expecting a 0.70% (60 pips) rise on break as first movement. After that, the price will keep going up and up, we can't know how much it can go but you can use my safe pivots trading.
SL == break below 0.85847
TP1 == 0.86691
TP2 == 0.87223
TP3 == 0.87930
This is not an investing advice, please calculate your risk and margin trading.
USDCHF Buy a break setup.USDCHF - Intraday - We look to Buy a break of 0.9302 (stop at 0.9278)
Daily signals are bullish.
Price action has formed a bullish ending wedge formation.
Trend line resistance is located at 0.9280.
A move through bespoke resistance at 0.9300 and we look for extended gains.
We look for gains to be extended today.
Our profit targets will be 0.9366 and 0.9396
Resistance: 0.9280 / 0.9300 / 0.9360
Support: 0.9250 / 0.9230 / 0.9200
GBP/NZD - Break of Ascending Structure Will we see further downside movement on this pair?
We saw a break of structure last week after price tagged the top of our ascending channel around a key long term level in the market. Will we see price cycle down to the bottom of previous structure?
This pair indicates strength vs strength in the forex markets at the moment. Want to know what this means? Drop me a message?